Racivir


Racivir is an experimental nucleoside reverse transcriptase inhibitor, developed by Pharmasset for the treatment of HIV. It is the enantiomer of emtricitabine, a widely used NRTI, meaning that the two compounds are mirror images of each other.
, the enantiomer of racivir and a widely used NRTI